Altrinsic Global Advisors LLC Decreases Stake in Healthpeak Properties, Inc. $DOC

Key Points

• Altrinsic Global Advisors LLC reduced its stake in Healthpeak Properties by 3.8%, owning 555,971 shares after selling 21,968 shares in the first quarter, which comprises 0.6% of its portfolio.
• Healthpeak Properties reported a net margin of 5.90% and a revenue of $694.35 million for the last quarter, slightly below analysts' expectations, with earnings per share meeting estimates at $0.46.
• The company's stock has experienced a decline of 0.5%, with recent price targets set lower by multiple analysts including Deutsche Bank and Wells Fargo, reflecting a consensus rating of "Moderate Buy."

Altrinsic Global Advisors LLC reduced its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 3.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 555,971 shares of the real estate investment trust's stock after selling 21,968 shares during the period. Healthpeak Properties accounts for about 0.6% of Altrinsic Global Advisors LLC's investment portfolio, making the stock its 27th largest holding. Altrinsic Global Advisors LLC owned about 0.08% of Healthpeak Properties worth $11,242,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. TCTC Holdings LLC lifted its position in Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after acquiring an additional 751 shares during the period. Brooklyn Investment Group lifted its position in Healthpeak Properties by 198.9% during the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after acquiring an additional 873 shares during the period. Future Financial Wealth Managment LLC purchased a new position in Healthpeak Properties during the 1st quarter valued at about $30,000. S.A. Mason LLC increased its stake in Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Finally, Dagco Inc. bought a new stake in Healthpeak Properties during the 1st quarter valued at about $30,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

NYSE:DOC traded up $0.09 during trading hours on Friday, hitting $17.95. 5,435,858 shares of the stock traded hands, compared to its average volume of 7,148,648. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a 1 year low of $16.63 and a 1 year high of $23.26. The company has a market cap of $12.47 billion, a price-to-earnings ratio of 74.79, a price-to-earnings-growth ratio of 2.30 and a beta of 1.05. The stock has a 50 day moving average price of $17.69 and a 200 day moving average price of $18.30.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same quarter in the prior year, the business earned $0.45 earnings per share. Healthpeak Properties's revenue for the quarter was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 18th were paid a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.8%. Healthpeak Properties's dividend payout ratio is presently 508.33%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 1,490 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the purchase, the chief executive officer directly owned 211,906 shares in the company, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have acquired a total of 8,783 shares of company stock worth $150,129 over the last quarter. 0.23% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

DOC has been the subject of a number of analyst reports. Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the company an "outperform" rating in a research note on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Morgan Stanley reduced their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Finally, Scotiabank lowered shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their price target for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Seven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, Healthpeak Properties currently has an average rating of "Moderate Buy" and a consensus target price of $21.50.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.